Rudolf Stadler Selected Research

Rudolf Stadler Research Topics

Disease

12	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 03/2022 - 02/2006
11	Melanoma (Melanoma, Malignant) 11/2022 - 01/2006
11	Mycosis Fungoides 03/2022 - 11/2012
8	Neoplasms (Cancer) 01/2022 - 09/2016
6	Lymphoma (Lymphomas) 01/2022 - 04/2013
3	Disease Progression 01/2021 - 02/2007
3	Pemphigus (Pemphigus Vulgaris) 07/2012 - 11/2006
2	Infections 01/2022 - 05/2011
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2021 - 01/2017
2	Sezary Syndrome (Sezary Erythroderma) 03/2020 - 01/2020
2	Neoplasm Metastasis (Metastasis) 11/2019 - 06/2016
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2013 - 05/2011
2	Bullous Pemphigoid (Pemphigoid) 07/2012 - 12/2007
1	Paraproteinemias (Monoclonal Gammopathy) 01/2022
1	Pain (Aches) 12/2021
1	Pruritus (Itching) 12/2021
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 12/2021
1	Neoplasm Micrometastasis 06/2016
1	Nephrogenic Fibrosing Dermopathy 03/2015
1	Rare Diseases (Rare Disease) 03/2015
1	Renal Insufficiency (Renal Failure) 03/2015
1	Inflammation (Inflammations) 11/2014
1	Seasonal Allergic Rhinitis (Hay Fever) 06/2013
1	Hypersensitivity (Allergy) 06/2013
1	Cardiotoxicity 04/2013
1	Autoimmune Diseases (Autoimmune Disease) 05/2011
1	Multiple Sclerosis 05/2011
1	Vasculitis (Vasculitides) 05/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2011
1	Rheumatoid Arthritis 05/2011
1	Systemic Scleroderma (Systemic Sclerosis) 01/2011
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 08/2009
1	Blister (Bulla) 12/2007
1	Hematologic Neoplasms (Hematological Malignancy) 02/2006

Drug/Important Bio-Agent (IBA)

5	Brentuximab VedotinIBA 01/2022 - 01/2017
4	AutoantibodiesIBA 07/2012 - 11/2006
2	Dihydrotachysterol (AT 10)IBA 11/2022 - 01/2020
2	Bexarotene (LGD1069)FDA Link 03/2022 - 12/2021
2	Rituximab (Mabthera)FDA Link 01/2022 - 05/2011
2	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2021 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 04/2013
2	Dacarbazine (DIC)FDA LinkGeneric 09/2017 - 01/2006
2	liposomal doxorubicin (Doxil)FDA Link 04/2013 - 11/2012
2	Interferon-alpha (Interferon Alfa)IBA 07/2009 - 01/2006
2	Interferon alpha-2 (Roferon-A)FDA Link 07/2009 - 01/2006
2	Azathioprine (Imuran)FDA LinkGeneric 12/2007 - 11/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2007 - 11/2006
2	Immunoglobulin G (IgG)IBA 12/2007 - 11/2006
2	Methylprednisolone FDA LinkGeneric 12/2007 - 11/2006
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 12/2007 - 11/2006
1	Gemcitabine FDA Link 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 12/2021
1	TTI-621IBA 11/2021
1	atezolizumabIBA 10/2021
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2021
1	ChromatinIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 03/2020
1	Adenosine Triphosphate (ATP)IBA 09/2017
1	Lenalidomide (CC 5013)FDA Link 06/2017
1	Midazolam (Versed)FDA LinkGeneric 09/2016
1	IpilimumabIBA 11/2015
1	GadoliniumIBA 03/2015
1	Contrast MediaIBA 03/2015
1	CytokinesIBA 11/2014
1	Anti-Allergic Agents (Antiallergic Agents)IBA 06/2013
1	1-dodecylpyridoxal (PLD)IBA 04/2013
1	AntigensIBA 07/2012
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2011
1	Imatinib Mesylate (Gleevec)FDA Link 08/2009
1	Ficusin (Psoralen)IBA 02/2007
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 02/2006
1	RetinoidsIBA 02/2006
1	Retinoid X Receptors (Retinoid X Receptor)IBA 02/2006

Therapy/Procedure

14	Therapeutics 03/2022 - 02/2007
4	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 06/2016
2	Drug Therapy (Chemotherapy) 01/2022 - 09/2017
2	Radiotherapy 01/2021 - 03/2020
2	Combination Drug Therapy (Combination Chemotherapy) 09/2017 - 04/2013
1	Stem Cell Transplantation 01/2021
1	Immunotherapy 11/2015
1	Self Medication 06/2013
1	Duration of Therapy 07/2009